ribozymes (Immusol)

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug Nameribozymes (Immusol)

Drug Alias NameN/A

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > OligonucleotideSmall molecules > Nucleosides and nucleotide derivtives > Ribozyme

Mechanisms of ActionVirus replication inhibitors

TargetsUpdating

Therapy Area/IndicationsHIV Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesItherx Pharmaceuticals Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesItherx Pharmaceuticals Inc

Active IndicationsN/A

Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A